Hong Kong stock moves | Fosun Pharma Hanlin (02696.HK) rose more than 3%, H-Drug Hanxizhuo approved for listing in Singapore and Malaysia.

According to the Securities Times App, Fuhong Hanlin (02696.HK) has risen more than 3%, as of the time of writing, it has increased by 3.19% to 48.5 Hong Kong dollars, with a turnover of 28.5384 million Hong Kong dollars.